Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Botulinum Neurotoxins market report explains the definition, types, applications, major countries, and major players of the Botulinum Neurotoxins market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
GSK
Chong Kun Dang
Escape Therapeutics
EpiVax
Lipella
Daewoong Pharmaceutical
Eisai
Malvern Cosmeceutics
PharmaVital
Merz Pharma
Nestle
Valeant Pharmaceuticals
Anterios
Alphaeon
Galderma
CNBG
OBI Pharma
Medy-Tox
Transdermal
Johnson & Johnson
CROMA
Hugel
Allergan
Revance Therapeutics
Ipsen
Mentor
By Type:
Botulinum Neurotoxins A (BoNT/A)
Botulinum Neurotoxins B (BoNT/B)
Botulinum Neurotoxins E (BoNT/E)
Botulinum Neurotoxins F (BoNT/F)
Botulinum Neurotoxins C (BoNT/C)
Botulinum Neurotoxins D (BoNT/D)
Botulinum Neurotoxins G (BoNT/G)
By End-User:
Medical Uses
Cosmetics
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Botulinum Neurotoxins Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Botulinum Neurotoxins Outlook to 2028- Original Forecasts
-
2.2 Botulinum Neurotoxins Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Botulinum Neurotoxins Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Botulinum Neurotoxins Market- Recent Developments
-
6.1 Botulinum Neurotoxins Market News and Developments
-
6.2 Botulinum Neurotoxins Market Deals Landscape
7 Botulinum Neurotoxins Raw Materials and Cost Structure Analysis
-
7.1 Botulinum Neurotoxins Key Raw Materials
-
7.2 Botulinum Neurotoxins Price Trend of Key Raw Materials
-
7.3 Botulinum Neurotoxins Key Suppliers of Raw Materials
-
7.4 Botulinum Neurotoxins Market Concentration Rate of Raw Materials
-
7.5 Botulinum Neurotoxins Cost Structure Analysis
-
7.5.1 Botulinum Neurotoxins Raw Materials Analysis
-
7.5.2 Botulinum Neurotoxins Labor Cost Analysis
-
7.5.3 Botulinum Neurotoxins Manufacturing Expenses Analysis
8 Global Botulinum Neurotoxins Import and Export Analysis (Top 10 Countries)
-
8.1 Global Botulinum Neurotoxins Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Botulinum Neurotoxins Export by Region (Top 10 Countries) (2017-2028)
9 Global Botulinum Neurotoxins Market Outlook by Types and Applications to 2022
-
9.1 Global Botulinum Neurotoxins Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Botulinum Neurotoxins A (BoNT/A) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Botulinum Neurotoxins B (BoNT/B) Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Botulinum Neurotoxins E (BoNT/E) Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Botulinum Neurotoxins F (BoNT/F) Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Botulinum Neurotoxins C (BoNT/C) Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Botulinum Neurotoxins D (BoNT/D) Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Botulinum Neurotoxins G (BoNT/G) Consumption and Growth Rate (2017-2022)
-
9.2 Global Botulinum Neurotoxins Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Medical Uses Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cosmetics Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Botulinum Neurotoxins Market Analysis and Outlook till 2022
-
10.1 Global Botulinum Neurotoxins Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Botulinum Neurotoxins Consumption (2017-2022)
-
10.2.2 Canada Botulinum Neurotoxins Consumption (2017-2022)
-
10.2.3 Mexico Botulinum Neurotoxins Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Botulinum Neurotoxins Consumption (2017-2022)
-
10.3.2 UK Botulinum Neurotoxins Consumption (2017-2022)
-
10.3.3 Spain Botulinum Neurotoxins Consumption (2017-2022)
-
10.3.4 Belgium Botulinum Neurotoxins Consumption (2017-2022)
-
10.3.5 France Botulinum Neurotoxins Consumption (2017-2022)
-
10.3.6 Italy Botulinum Neurotoxins Consumption (2017-2022)
-
10.3.7 Denmark Botulinum Neurotoxins Consumption (2017-2022)
-
10.3.8 Finland Botulinum Neurotoxins Consumption (2017-2022)
-
10.3.9 Norway Botulinum Neurotoxins Consumption (2017-2022)
-
10.3.10 Sweden Botulinum Neurotoxins Consumption (2017-2022)
-
10.3.11 Poland Botulinum Neurotoxins Consumption (2017-2022)
-
10.3.12 Russia Botulinum Neurotoxins Consumption (2017-2022)
-
10.3.13 Turkey Botulinum Neurotoxins Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Botulinum Neurotoxins Consumption (2017-2022)
-
10.4.2 Japan Botulinum Neurotoxins Consumption (2017-2022)
-
10.4.3 India Botulinum Neurotoxins Consumption (2017-2022)
-
10.4.4 South Korea Botulinum Neurotoxins Consumption (2017-2022)
-
10.4.5 Pakistan Botulinum Neurotoxins Consumption (2017-2022)
-
10.4.6 Bangladesh Botulinum Neurotoxins Consumption (2017-2022)
-
10.4.7 Indonesia Botulinum Neurotoxins Consumption (2017-2022)
-
10.4.8 Thailand Botulinum Neurotoxins Consumption (2017-2022)
-
10.4.9 Singapore Botulinum Neurotoxins Consumption (2017-2022)
-
10.4.10 Malaysia Botulinum Neurotoxins Consumption (2017-2022)
-
10.4.11 Philippines Botulinum Neurotoxins Consumption (2017-2022)
-
10.4.12 Vietnam Botulinum Neurotoxins Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Botulinum Neurotoxins Consumption (2017-2022)
-
10.5.2 Colombia Botulinum Neurotoxins Consumption (2017-2022)
-
10.5.3 Chile Botulinum Neurotoxins Consumption (2017-2022)
-
10.5.4 Argentina Botulinum Neurotoxins Consumption (2017-2022)
-
10.5.5 Venezuela Botulinum Neurotoxins Consumption (2017-2022)
-
10.5.6 Peru Botulinum Neurotoxins Consumption (2017-2022)
-
10.5.7 Puerto Rico Botulinum Neurotoxins Consumption (2017-2022)
-
10.5.8 Ecuador Botulinum Neurotoxins Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Botulinum Neurotoxins Consumption (2017-2022)
-
10.6.2 Kuwait Botulinum Neurotoxins Consumption (2017-2022)
-
10.6.3 Oman Botulinum Neurotoxins Consumption (2017-2022)
-
10.6.4 Qatar Botulinum Neurotoxins Consumption (2017-2022)
-
10.6.5 Saudi Arabia Botulinum Neurotoxins Consumption (2017-2022)
-
10.6.6 United Arab Emirates Botulinum Neurotoxins Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Botulinum Neurotoxins Consumption (2017-2022)
-
10.7.2 South Africa Botulinum Neurotoxins Consumption (2017-2022)
-
10.7.3 Egypt Botulinum Neurotoxins Consumption (2017-2022)
-
10.7.4 Algeria Botulinum Neurotoxins Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Botulinum Neurotoxins Consumption (2017-2022)
-
10.8.2 New Zealand Botulinum Neurotoxins Consumption (2017-2022)
11 Global Botulinum Neurotoxins Competitive Analysis
-
11.1 GSK
-
11.1.1 GSK Company Details
-
11.1.2 GSK Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 GSK Botulinum Neurotoxins Main Business and Markets Served
-
11.1.4 GSK Botulinum Neurotoxins Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Chong Kun Dang
-
11.2.1 Chong Kun Dang Company Details
-
11.2.2 Chong Kun Dang Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Chong Kun Dang Botulinum Neurotoxins Main Business and Markets Served
-
11.2.4 Chong Kun Dang Botulinum Neurotoxins Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Escape Therapeutics
-
11.3.1 Escape Therapeutics Company Details
-
11.3.2 Escape Therapeutics Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Escape Therapeutics Botulinum Neurotoxins Main Business and Markets Served
-
11.3.4 Escape Therapeutics Botulinum Neurotoxins Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 EpiVax
-
11.4.1 EpiVax Company Details
-
11.4.2 EpiVax Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 EpiVax Botulinum Neurotoxins Main Business and Markets Served
-
11.4.4 EpiVax Botulinum Neurotoxins Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Lipella
-
11.5.1 Lipella Company Details
-
11.5.2 Lipella Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Lipella Botulinum Neurotoxins Main Business and Markets Served
-
11.5.4 Lipella Botulinum Neurotoxins Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Daewoong Pharmaceutical
-
11.6.1 Daewoong Pharmaceutical Company Details
-
11.6.2 Daewoong Pharmaceutical Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Daewoong Pharmaceutical Botulinum Neurotoxins Main Business and Markets Served
-
11.6.4 Daewoong Pharmaceutical Botulinum Neurotoxins Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Eisai
-
11.7.1 Eisai Company Details
-
11.7.2 Eisai Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Eisai Botulinum Neurotoxins Main Business and Markets Served
-
11.7.4 Eisai Botulinum Neurotoxins Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Malvern Cosmeceutics
-
11.8.1 Malvern Cosmeceutics Company Details
-
11.8.2 Malvern Cosmeceutics Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Malvern Cosmeceutics Botulinum Neurotoxins Main Business and Markets Served
-
11.8.4 Malvern Cosmeceutics Botulinum Neurotoxins Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 PharmaVital
-
11.9.1 PharmaVital Company Details
-
11.9.2 PharmaVital Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 PharmaVital Botulinum Neurotoxins Main Business and Markets Served
-
11.9.4 PharmaVital Botulinum Neurotoxins Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Merz Pharma
-
11.10.1 Merz Pharma Company Details
-
11.10.2 Merz Pharma Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Merz Pharma Botulinum Neurotoxins Main Business and Markets Served
-
11.10.4 Merz Pharma Botulinum Neurotoxins Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Nestle
-
11.11.1 Nestle Company Details
-
11.11.2 Nestle Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Nestle Botulinum Neurotoxins Main Business and Markets Served
-
11.11.4 Nestle Botulinum Neurotoxins Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Valeant Pharmaceuticals
-
11.12.1 Valeant Pharmaceuticals Company Details
-
11.12.2 Valeant Pharmaceuticals Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Valeant Pharmaceuticals Botulinum Neurotoxins Main Business and Markets Served
-
11.12.4 Valeant Pharmaceuticals Botulinum Neurotoxins Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Anterios
-
11.13.1 Anterios Company Details
-
11.13.2 Anterios Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Anterios Botulinum Neurotoxins Main Business and Markets Served
-
11.13.4 Anterios Botulinum Neurotoxins Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Alphaeon
-
11.14.1 Alphaeon Company Details
-
11.14.2 Alphaeon Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Alphaeon Botulinum Neurotoxins Main Business and Markets Served
-
11.14.4 Alphaeon Botulinum Neurotoxins Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Galderma
-
11.15.1 Galderma Company Details
-
11.15.2 Galderma Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Galderma Botulinum Neurotoxins Main Business and Markets Served
-
11.15.4 Galderma Botulinum Neurotoxins Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 CNBG
-
11.16.1 CNBG Company Details
-
11.16.2 CNBG Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 CNBG Botulinum Neurotoxins Main Business and Markets Served
-
11.16.4 CNBG Botulinum Neurotoxins Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 OBI Pharma
-
11.17.1 OBI Pharma Company Details
-
11.17.2 OBI Pharma Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 OBI Pharma Botulinum Neurotoxins Main Business and Markets Served
-
11.17.4 OBI Pharma Botulinum Neurotoxins Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Medy-Tox
-
11.18.1 Medy-Tox Company Details
-
11.18.2 Medy-Tox Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Medy-Tox Botulinum Neurotoxins Main Business and Markets Served
-
11.18.4 Medy-Tox Botulinum Neurotoxins Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Transdermal
-
11.19.1 Transdermal Company Details
-
11.19.2 Transdermal Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Transdermal Botulinum Neurotoxins Main Business and Markets Served
-
11.19.4 Transdermal Botulinum Neurotoxins Product Portfolio
-
11.19.5 Recent Research and Development Strategies
-
11.20 Johnson & Johnson
-
11.20.1 Johnson & Johnson Company Details
-
11.20.2 Johnson & Johnson Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
11.20.3 Johnson & Johnson Botulinum Neurotoxins Main Business and Markets Served
-
11.20.4 Johnson & Johnson Botulinum Neurotoxins Product Portfolio
-
11.20.5 Recent Research and Development Strategies
-
11.21 CROMA
-
11.21.1 CROMA Company Details
-
11.21.2 CROMA Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
11.21.3 CROMA Botulinum Neurotoxins Main Business and Markets Served
-
11.21.4 CROMA Botulinum Neurotoxins Product Portfolio
-
11.21.5 Recent Research and Development Strategies
-
11.22 Hugel
-
11.22.1 Hugel Company Details
-
11.22.2 Hugel Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
11.22.3 Hugel Botulinum Neurotoxins Main Business and Markets Served
-
11.22.4 Hugel Botulinum Neurotoxins Product Portfolio
-
11.22.5 Recent Research and Development Strategies
-
11.23 Allergan
-
11.23.1 Allergan Company Details
-
11.23.2 Allergan Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
11.23.3 Allergan Botulinum Neurotoxins Main Business and Markets Served
-
11.23.4 Allergan Botulinum Neurotoxins Product Portfolio
-
11.23.5 Recent Research and Development Strategies
-
11.24 Revance Therapeutics
-
11.24.1 Revance Therapeutics Company Details
-
11.24.2 Revance Therapeutics Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
11.24.3 Revance Therapeutics Botulinum Neurotoxins Main Business and Markets Served
-
11.24.4 Revance Therapeutics Botulinum Neurotoxins Product Portfolio
-
11.24.5 Recent Research and Development Strategies
-
11.25 Ipsen
-
11.25.1 Ipsen Company Details
-
11.25.2 Ipsen Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
11.25.3 Ipsen Botulinum Neurotoxins Main Business and Markets Served
-
11.25.4 Ipsen Botulinum Neurotoxins Product Portfolio
-
11.25.5 Recent Research and Development Strategies
-
11.26 Mentor
-
11.26.1 Mentor Company Details
-
11.26.2 Mentor Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
11.26.3 Mentor Botulinum Neurotoxins Main Business and Markets Served
-
11.26.4 Mentor Botulinum Neurotoxins Product Portfolio
-
11.26.5 Recent Research and Development Strategies
12 Global Botulinum Neurotoxins Market Outlook by Types and Applications to 2028
-
12.1 Global Botulinum Neurotoxins Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Botulinum Neurotoxins A (BoNT/A) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Botulinum Neurotoxins B (BoNT/B) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Botulinum Neurotoxins E (BoNT/E) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Botulinum Neurotoxins F (BoNT/F) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Botulinum Neurotoxins C (BoNT/C) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.6 Global Botulinum Neurotoxins D (BoNT/D) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.7 Global Botulinum Neurotoxins G (BoNT/G) Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Botulinum Neurotoxins Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Medical Uses Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Cosmetics Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Botulinum Neurotoxins Market Analysis and Outlook to 2028
-
13.1 Global Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.2.2 Canada Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.2.3 Mexico Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.3.2 UK Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.3.3 Spain Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.3.4 Belgium Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.3.5 France Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.3.6 Italy Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.3.7 Denmark Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.3.8 Finland Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.3.9 Norway Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.3.10 Sweden Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.3.11 Poland Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.3.12 Russia Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.3.13 Turkey Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.4.2 Japan Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.4.3 India Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.4.4 South Korea Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.4.8 Thailand Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.4.9 Singapore Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.4.11 Philippines Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.5.2 Colombia Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.5.3 Chile Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.5.4 Argentina Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.5.6 Peru Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.6.3 Oman Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.6.4 Qatar Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.7.2 South Africa Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.7.3 Egypt Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.7.4 Algeria Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Botulinum Neurotoxins Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Botulinum Neurotoxins Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Botulinum Neurotoxins
-
Figure of Botulinum Neurotoxins Picture
-
Table Global Botulinum Neurotoxins Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Botulinum Neurotoxins Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Botulinum Neurotoxins A (BoNT/A) Consumption and Growth Rate (2017-2022)
-
Figure Global Botulinum Neurotoxins B (BoNT/B) Consumption and Growth Rate (2017-2022)
-
Figure Global Botulinum Neurotoxins E (BoNT/E) Consumption and Growth Rate (2017-2022)
-
Figure Global Botulinum Neurotoxins F (BoNT/F) Consumption and Growth Rate (2017-2022)
-
Figure Global Botulinum Neurotoxins C (BoNT/C) Consumption and Growth Rate (2017-2022)
-
Figure Global Botulinum Neurotoxins D (BoNT/D) Consumption and Growth Rate (2017-2022)
-
Figure Global Botulinum Neurotoxins G (BoNT/G) Consumption and Growth Rate (2017-2022)
-
Figure Global Medical Uses Consumption and Growth Rate (2017-2022)
-
Figure Global Cosmetics Consumption and Growth Rate (2017-2022)
-
Figure Global Botulinum Neurotoxins Consumption by Country (2017-2022)
-
Table North America Botulinum Neurotoxins Consumption by Country (2017-2022)
-
Figure United States Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Canada Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Mexico Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Table Europe Botulinum Neurotoxins Consumption by Country (2017-2022)
-
Figure Germany Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure UK Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Spain Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Belgium Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure France Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Italy Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Denmark Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Finland Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Norway Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Sweden Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Poland Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Russia Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Turkey Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Table APAC Botulinum Neurotoxins Consumption by Country (2017-2022)
-
Figure China Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Japan Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure India Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure South Korea Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Thailand Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Singapore Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Philippines Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Table South America Botulinum Neurotoxins Consumption by Country (2017-2022)
-
Figure Brazil Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Colombia Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Chile Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Argentina Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Peru Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Table GCC Botulinum Neurotoxins Consumption by Country (2017-2022)
-
Figure Bahrain Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Oman Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Qatar Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Table Africa Botulinum Neurotoxins Consumption by Country (2017-2022)
-
Figure Nigeria Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure South Africa Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Egypt Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure Algeria Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Table Oceania Botulinum Neurotoxins Consumption by Country (2017-2022)
-
Figure Australia Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Botulinum Neurotoxins Consumption and Growth Rate (2017-2022)
-
Table GSK Company Details
-
Table GSK Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Botulinum Neurotoxins Main Business and Markets Served
-
Table GSK Botulinum Neurotoxins Product Portfolio
-
Table Chong Kun Dang Company Details
-
Table Chong Kun Dang Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chong Kun Dang Botulinum Neurotoxins Main Business and Markets Served
-
Table Chong Kun Dang Botulinum Neurotoxins Product Portfolio
-
Table Escape Therapeutics Company Details
-
Table Escape Therapeutics Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Escape Therapeutics Botulinum Neurotoxins Main Business and Markets Served
-
Table Escape Therapeutics Botulinum Neurotoxins Product Portfolio
-
Table EpiVax Company Details
-
Table EpiVax Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table EpiVax Botulinum Neurotoxins Main Business and Markets Served
-
Table EpiVax Botulinum Neurotoxins Product Portfolio
-
Table Lipella Company Details
-
Table Lipella Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lipella Botulinum Neurotoxins Main Business and Markets Served
-
Table Lipella Botulinum Neurotoxins Product Portfolio
-
Table Daewoong Pharmaceutical Company Details
-
Table Daewoong Pharmaceutical Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daewoong Pharmaceutical Botulinum Neurotoxins Main Business and Markets Served
-
Table Daewoong Pharmaceutical Botulinum Neurotoxins Product Portfolio
-
Table Eisai Company Details
-
Table Eisai Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Botulinum Neurotoxins Main Business and Markets Served
-
Table Eisai Botulinum Neurotoxins Product Portfolio
-
Table Malvern Cosmeceutics Company Details
-
Table Malvern Cosmeceutics Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Malvern Cosmeceutics Botulinum Neurotoxins Main Business and Markets Served
-
Table Malvern Cosmeceutics Botulinum Neurotoxins Product Portfolio
-
Table PharmaVital Company Details
-
Table PharmaVital Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table PharmaVital Botulinum Neurotoxins Main Business and Markets Served
-
Table PharmaVital Botulinum Neurotoxins Product Portfolio
-
Table Merz Pharma Company Details
-
Table Merz Pharma Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merz Pharma Botulinum Neurotoxins Main Business and Markets Served
-
Table Merz Pharma Botulinum Neurotoxins Product Portfolio
-
Table Nestle Company Details
-
Table Nestle Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nestle Botulinum Neurotoxins Main Business and Markets Served
-
Table Nestle Botulinum Neurotoxins Product Portfolio
-
Table Valeant Pharmaceuticals Company Details
-
Table Valeant Pharmaceuticals Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valeant Pharmaceuticals Botulinum Neurotoxins Main Business and Markets Served
-
Table Valeant Pharmaceuticals Botulinum Neurotoxins Product Portfolio
-
Table Anterios Company Details
-
Table Anterios Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Anterios Botulinum Neurotoxins Main Business and Markets Served
-
Table Anterios Botulinum Neurotoxins Product Portfolio
-
Table Alphaeon Company Details
-
Table Alphaeon Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alphaeon Botulinum Neurotoxins Main Business and Markets Served
-
Table Alphaeon Botulinum Neurotoxins Product Portfolio
-
Table Galderma Company Details
-
Table Galderma Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Galderma Botulinum Neurotoxins Main Business and Markets Served
-
Table Galderma Botulinum Neurotoxins Product Portfolio
-
Table CNBG Company Details
-
Table CNBG Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table CNBG Botulinum Neurotoxins Main Business and Markets Served
-
Table CNBG Botulinum Neurotoxins Product Portfolio
-
Table OBI Pharma Company Details
-
Table OBI Pharma Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table OBI Pharma Botulinum Neurotoxins Main Business and Markets Served
-
Table OBI Pharma Botulinum Neurotoxins Product Portfolio
-
Table Medy-Tox Company Details
-
Table Medy-Tox Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Medy-Tox Botulinum Neurotoxins Main Business and Markets Served
-
Table Medy-Tox Botulinum Neurotoxins Product Portfolio
-
Table Transdermal Company Details
-
Table Transdermal Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Transdermal Botulinum Neurotoxins Main Business and Markets Served
-
Table Transdermal Botulinum Neurotoxins Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Botulinum Neurotoxins Main Business and Markets Served
-
Table Johnson & Johnson Botulinum Neurotoxins Product Portfolio
-
Table CROMA Company Details
-
Table CROMA Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table CROMA Botulinum Neurotoxins Main Business and Markets Served
-
Table CROMA Botulinum Neurotoxins Product Portfolio
-
Table Hugel Company Details
-
Table Hugel Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hugel Botulinum Neurotoxins Main Business and Markets Served
-
Table Hugel Botulinum Neurotoxins Product Portfolio
-
Table Allergan Company Details
-
Table Allergan Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Botulinum Neurotoxins Main Business and Markets Served
-
Table Allergan Botulinum Neurotoxins Product Portfolio
-
Table Revance Therapeutics Company Details
-
Table Revance Therapeutics Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Revance Therapeutics Botulinum Neurotoxins Main Business and Markets Served
-
Table Revance Therapeutics Botulinum Neurotoxins Product Portfolio
-
Table Ipsen Company Details
-
Table Ipsen Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ipsen Botulinum Neurotoxins Main Business and Markets Served
-
Table Ipsen Botulinum Neurotoxins Product Portfolio
-
Table Mentor Company Details
-
Table Mentor Botulinum Neurotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mentor Botulinum Neurotoxins Main Business and Markets Served
-
Table Mentor Botulinum Neurotoxins Product Portfolio
-
Figure Global Botulinum Neurotoxins A (BoNT/A) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Botulinum Neurotoxins B (BoNT/B) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Botulinum Neurotoxins E (BoNT/E) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Botulinum Neurotoxins F (BoNT/F) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Botulinum Neurotoxins C (BoNT/C) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Botulinum Neurotoxins D (BoNT/D) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Botulinum Neurotoxins G (BoNT/G) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Medical Uses Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cosmetics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Botulinum Neurotoxins Consumption Forecast by Country (2022-2028)
-
Table North America Botulinum Neurotoxins Consumption Forecast by Country (2022-2028)
-
Figure United States Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Botulinum Neurotoxins Consumption Forecast by Country (2022-2028)
-
Figure Germany Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Botulinum Neurotoxins Consumption Forecast by Country (2022-2028)
-
Figure China Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Botulinum Neurotoxins Consumption Forecast by Country (2022-2028)
-
Figure Brazil Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Botulinum Neurotoxins Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Botulinum Neurotoxins Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Botulinum Neurotoxins Consumption Forecast by Country (2022-2028)
-
Figure Australia Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Botulinum Neurotoxins Consumption Forecast and Growth Rate (2022-2028)
-
